Ryclora
(Dexchlorpheniramine Maleate)Ryclora Prescribing Information
Perennial and seasonal allergic rhinitis
Vasomotor rhinitis
Allergic conjunctivitis due to inhalant allergens and foods
Mild, uncomplicated allergic skin manifestations of urticaria and angioedema
Amelioration of allergic reactions to blood or plasma
Dermographism
As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.
This drug should not be used in newborn or premature infants.
- General:Urticaria, drug rash, anaphylactic shock, photosensitivity, excessive perspiration, chills, dryness of mouth, nose and the throat.
- Cardiovascular System:Hemolytic anemia, thrombocytopenia, agranulocytosis.
- Hematologic System:Hemolytic anemia, thrombocytopenia, agranulocytosis.
- Nervous System:Sedation, sleepiness, dizziness, disturbed coordination, fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesias, blurred vision, diplopia, vertigo, tinnitus, acute labyrinthitis, hysteria, neuritis, convulsions.
- G.I. System:Epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation.
- G.U. System:Urinary frequency, difficult urination, urinary retention, early menses.
- Respiratory System:Thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness.
MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.
Each 5 mL (teaspoonful) contains: | |
| Dexchlorpheniramine Maleate, USP | 2 mg |
Dexchlorpheniramine Maleate, USP, an antihistamine agent, is a white, odorless crystalline powder that is freely soluble in water. The molecular formula is C16H19ClN2 ∙ C4H4O4, designated chemically as (+)-2-[p-Chloro-α-[2-(dimethylamino)ethyl]benzyl] pyridine maleate (1:1).

M.W. = 390.86